Weight loss medication for young adults with type 1 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether a GLP-1 medication (a type of drug that helps with weight loss) can safely and effectively help young adults with type 1 diabetes who also have obesity. It aims to see if adding this treatment to insulin can improve weight and blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 30 years old.
- You have type 1 diabetes that was diagnosed at least 1 year ago.
- Your BMI is 30 or higher (or 27 or higher with a weight-related health condition).
- Your average blood sugar (HbA1c) is 10% or lower.
- Your insulin dose and weight have been stable for the past 3 months.
- You are not currently pregnant, planning pregnancy, or breastfeeding, and you use effective birth control if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a nasal spray containing semaglutide (a GLP-1 receptor agonist) to see if it helps adults who are overweight or obese lose weight. It may be an option if you have a BMI between 27 and 35 and have not used other weight loss medications recently.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.
This study tests a weekly injection called semaglutide to see how well it helps people with obesity lose weight, compared to a similar approved medicine, Wegovy. It may be an option if you have struggled to lose weight in the past.
Hear when a new Diabetes type1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.